Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.55
-0.15 (-0.80%)
Jul 11, 2025, 1:54 PM CST

Genomics BioSci & Tech. Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
172.58253.03317107.5476.94
Upgrade
Short-Term Investments
65---98
Upgrade
Cash & Short-Term Investments
237.58253.03317107.5574.94
Upgrade
Cash Growth
-6.11%-20.18%194.90%-81.30%36.20%
Upgrade
Accounts Receivable
138.86116.1100.0281.7579.18
Upgrade
Other Receivables
0.390.740.011.440.58
Upgrade
Receivables
139.25116.84100.0283.279.77
Upgrade
Inventory
185.4961.5154.820.9924
Upgrade
Prepaid Expenses
18.0916.858.8321.9226.88
Upgrade
Other Current Assets
34.7723.5817.4518.2312.38
Upgrade
Total Current Assets
615.19471.82498.1251.83717.96
Upgrade
Property, Plant & Equipment
648.43498.69373.37311.02306
Upgrade
Long-Term Investments
82153.98237.96285.83110.32
Upgrade
Other Intangible Assets
5.771.730.861.163.92
Upgrade
Long-Term Accounts Receivable
0.64----
Upgrade
Long-Term Deferred Tax Assets
---0.070.1
Upgrade
Other Long-Term Assets
8.337.639.443.2716.96
Upgrade
Total Assets
1,3601,1341,120853.181,155
Upgrade
Accounts Payable
97.429.7340.4727.3131.41
Upgrade
Accrued Expenses
35.428.734.527.5471.93
Upgrade
Short-Term Debt
128.965050-50
Upgrade
Current Portion of Long-Term Debt
35.414.8612.43.93.87
Upgrade
Current Portion of Leases
6.436.514.753.395.23
Upgrade
Current Income Taxes Payable
--0.58--
Upgrade
Current Unearned Revenue
43.6912.722018.8911.99
Upgrade
Other Current Liabilities
35.4813.576.2113.5714.58
Upgrade
Total Current Liabilities
382.77146.09168.9194.59189.02
Upgrade
Long-Term Debt
328.89214.01153.3575.6744.22
Upgrade
Long-Term Leases
7.988.248.343.5814.32
Upgrade
Total Liabilities
719.64368.33330.6173.84247.56
Upgrade
Common Stock
724.48724.48630.28578.92578.92
Upgrade
Additional Paid-In Capital
30.15131.5358.9143.7638.88
Upgrade
Retained Earnings
-204.06-88.24101.8536.0716.09
Upgrade
Comprehensive Income & Other
-1.84-2.25-1.9120.5938.29
Upgrade
Total Common Equity
548.73765.51789.13679.34672.18
Upgrade
Minority Interest
91.99---235.52
Upgrade
Shareholders' Equity
640.73765.51789.13679.34907.7
Upgrade
Total Liabilities & Equity
1,3601,1341,120853.181,155
Upgrade
Total Debt
507.67283.61228.8486.53117.64
Upgrade
Net Cash (Debt)
-270.08-30.5888.1720.96457.3
Upgrade
Net Cash Growth
--320.57%-95.42%24.15%
Upgrade
Net Cash Per Share
-3.73-0.431.390.357.58
Upgrade
Filing Date Shares Outstanding
72.4572.4564.2960.2360.23
Upgrade
Total Common Shares Outstanding
72.4572.4564.2960.2360.23
Upgrade
Working Capital
232.42325.73329.19157.24528.94
Upgrade
Book Value Per Share
7.5710.5712.2711.2811.16
Upgrade
Tangible Book Value
542.96763.78788.27678.18668.26
Upgrade
Tangible Book Value Per Share
7.4910.5412.2611.2611.10
Upgrade
Land
206.74139.79104.76104.7686.67
Upgrade
Buildings
256.36211.33144.63134.61101.25
Upgrade
Machinery
234.39231.91142.81150.45234.52
Upgrade
Construction In Progress
52.590.2379.4526.25-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.